Physician profile
Robert B Hansen
NPI 1619969227
$9,296.45
in general payments reported to CMS, 2019-2025
46 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,885 · 2020: $2,338 · 2021: $1,776 · 2022: $1,617 · 2023: $1,313 · 2024: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,362.92 | 2021-2024 | |
| Allergan, INC. | $1,173.82 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $798.11 | 2019-2024 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $660.28 | 2019-2023 | Relistor |
| Lundbeck LLC | $660.21 | 2020-2024 | Vyepti |
| Novartis Pharmaceuticals Corporation | $609.15 | 2019-2021 | |
| Amgen INC. | $578.47 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $301.18 | 2019-2023 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $294.45 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $269.97 | 2022 | |
| Pfizer INC. | $255.15 | 2019-2024 | |
| Scilex Pharmaceuticals INC. | $222.51 | 2019 | |
| Upsher-Smith Laboratories LLC | $210.66 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $200.63 | 2019-2022 | |
| Zyla Life Sciences, INC. | $126.65 | 2019-2020 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.